Thrombosis Prophylaxis in Obstetrics and Gynaecology

Department of Health, Welsh Office, Scottish Home and Health Department and Department of Health and Social Services, Northern Ireland. Confidential enquiries into maternal deaths in the United Kingdom 1988–89. London: HMSO, 1994.

Genton E Turpie AGG . Venous thromboembolism associated with gynaecologic surgery. Clin Obstet Gynaecol 1980; 23: 209–41.

Report of the National Confidential Enquiry into Perioperative Deaths 1991/92. London: HMSO, 1993.

Hiilesmaa V. Occurrence and anticoagulant treatment of thromboembolism in gravidas, parturients and gynaecological patients. A study of 678 cases treated in the Women's Clinic of the University of Helsinki. Acta Obstet Gynecol Scand Suppl 1960; 2: 1953–57.

Aaro LA Juergens JL . Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol 1971; 109: 1128–33.

Coon W Willis P Keller J. Venous thromboembolism and other venous diseases in the Tecumesh community health study. Circulation 1973; 48: 839–46.

Daniel DG Campbell H Turnbull AC . Puerperal thromboembolism and suppression of lactation. Lancet 1967; ii: 287–89.

Husni E Pena L Lenhert E. Thrombophlebitis in pregnancy. Am J Obstet Gynecol 1967; 97: 901–905.

Flessa HC Glueck HI Dritschilo A. Thrombembolic disorders in pregnancy. Clin Obstet Gynaecol 1974; 17: 195–235.

Bergqvist A Bergqvist D Hallbrook T. Deep vein thrombosis during pregnancy. Acta Obstet Gynecol Scand 1983; 62: 443–48.

Bergqvist A Bergqvist D Hallbrook T. Acute deep venous thrombosis after caesarean section. Acta Obstet Gynecol Scand 1979; 58: 473–76.

Letsky E de Swiet M. Thromboembolism in pregnancy and its management. Br J Haematol 1984; 57: 543–52.

Macklon NS Barry J Greer IA . Duplex ultrasound screening for deep venous thrombosis in the puerperium. Br J Obstet Gynaecol 1995; 102: 255–56.

Lindhagen A Bergqvist A Bergqvist D Hallbrook T. Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy. Br J Obstet Gynaecol 1986; 93: 348–52.

Bergqvist D Bergqvist A Lindhagen A Matzsch T. Long term outcome of patients with venous thromboembolism during pregnancy. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 349–60.

Lindhagen A Bergqvist D Hallbrook T. Deep venous insufficiency after postoperative thrombosis diagnosed with ¹²⁵I-labelled fibrinogen uptake test. Br J Surg 1984; 71: 511–15.

Lindhagen A Bergqvist D Hallbrook T Elsing HO . Venous function five to eight years after clinically suspected deep venous thrombosis. Acta Med Scand 1985; 217: 389–95.

Department of Health. Confidential enquiries into maternal deaths in England and Wales 1982–84. London: HMSO, 1989.

Macklon NS Greer IA . Venous thromboembolic disease in obstetrics and gynaecology: The Scottish experience. Scott Med J 1995 (in press).

Bergqvist D Lindblad B Matzsch T. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia – is there a risk? Acta Anaesthesiol Scand 1992; 36: 605–609.

Tengborn L Bergqvist D Matzsch T Bergqvist A Hednar V. Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis? Am J Obstet Gynecol 1989; 160: 90–95.

de Swiet M Floyd E Letsky E. Low risk of recurrent thromboembolism in pregnancy. Br J Hosp Med 1987; 38: 264.

Thomas AN Pattison E Serjeant GR . Causes of death in sickle-cell disease in Jamaica. Br Med J 1982; 285: 633–35.

Van Dinh T Boor PJ Gazra JR . Massive pulmonary embolism following delivery of a patient with sickle cell trait. Am J Obstet Gynecol 1982; 143: 722–24.

Jick H Slone D Westerholm B Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; i: 539–42.

Koster T Rosendaal FR de Ronde H Briet E Vandenbrouke JP Bertina RM . Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503–506.

Greer IA de Swiet M. Thombosis prophylaxis in obstetrics and gynaecology. Br J Obstet Gynaecol 1993; 100: 37–40.

Flessa HC Kapstrom AB Glueck HI Will JJ . Placental transport of heparin. Am J Obstet Gynecol 1965; 93: 570–73.

Forestier F Daffos F Capella-Pavlovsky M. Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: Study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557–60.

Forestier F Daffos F Rainaux M Toulemonde F. Low molecular weight heparin (CY216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost 1987; 57: 234.

Andrew M Boneu B Cade J Placental transport of low molecular weight heparin in the pregnant sheep. Br J Haematol 1985; 59: 103–108.

Omri A Delaloye JF Anderson H Bachman F. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 1989; 61: 55–56.

Dahlman T Lindvall N Hellgren M. Osteopenia in pregnancy during long-term heparin treatment: A radiological study post partum. Br J Obstet Gynaecol 1990; 97: 221–28.

Hirsh J. Heparin. N Engl J Med 1991; 324: 1565–74.

Ginsberg JS Kowalchuk G Hirsh J Heparin effect on bone density. Thromb Haemost 1990; 64: 286–89.

de Swiet M Ward Dorrington P Prolonged heparin therapy in pregnancy causes bone demineralisation (heparin-induced osteopenia). Br J Obstet Gynaecol 1983; 90: 1129–34.

Barbour LA Kick SD Steiner JF . A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994; 170: 862–69.

Dahlman TC . Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168: 1265–70.

Matzsch T Bergqvist D Hedner U Nilsson B Ostergaard P. Induction of osteoporosis in rats by standard heparin and low molecular weight heparin. Thromb Haemost 1987; 58: 36.

Melissari E Parker CJ Wilson NV Monte G Kanthou C. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992; 68: 652–56.

Zimran A Shilo S Fisher D Bab I. Histomorphometric evaluation of reversible heparin induced osteoporosis in pregnancy. Arch Intern med 1986; 146: 386–88.

King DJ Kelton JG . Heparin associated thrombocytopaenia. Ann Intern Med 1984; 100: 535–40.

Harenberg J Leber G Zimmerman R Schmidt W. Thromboemboleprophylaxe mit nieder molekularem Heparin in der Schwangenschaft. Geburtshilfe Frauenheilkd 1987; 47: 15–18.

Henny CP ten Cate H ten Cate JW Prummel MF Peters M Buller HR . Thrombosis prophylaxis in an ATIII deficient pregnant woman: Application of low molecular weight heparinoid. Thromb Haemost 1986; 55: 301.

van Besien K Hoffman R Golichowski A. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: Management with a low molecular weight heparinoid. Thromb Res 1991; 62: 23–29.

Macklon NS Greer IA Reid AJ Walker ID . Heparin induced thrombocytopenia, antithrombin III deficiency and extensive thromboembolism in pregnancy: Treatment with low molecular weight heparin. Blood Coagulat Fibrinol 1995: In press.

Hall JG Pauli RM Wilson KM . Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980; 68: 122–40.

Ginsberg JS Hirsh J Turner DC Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989; 61: 197–203.

Ginsberg JS . Fetal abnormalities and anticoagulants. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1991: 361–69.

Stevenson RE Burton M Ferlauto GJ Taylor HA . Hazards of oral anticoagulants during pregnancy. JAMA 1980; 243: 1549–51.

Cox DR Martin L Hall BD . Asplenia syndrome after fetal exposure to warfarin. Lancet 1977; ii: 1134.

Iturbe-Alessio I del Carmen Fonseca M Mutchinik O Santos MA Zajarias A Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986; 315: 1390–93.

Chong MKB Harvey D de Swiet M. Follow up of children whose mothers were treated with warfarin during pregnancy. Br J Obstet Gynaecol 1984; 91: 1070–73.

Chen WCC Chan CS Lee PK Wang RYC Wong VCW . Pregnancy in patients with prosthetic heart valves: An experience with 45 pregnancies. Q J Med 1982; LI: 358–65.

de Swiet M Letsky E Mellows H. Drug treatment and prophylaxis of thromboembolism in pregnancy. In: Lewis PJ ed. Therapeutic problems in pregnancy. Lancaster: MTP, 1977: 81–89.

Santa Villa U. Thromboembolic disease in pregnancy. Am J Obstet Gynecol 1965; 93: 142.

Salazar E Zajarias A Gutierrez N Iturbe I. The problem of cardiac valve prostheses anticoagulants and pregnancy. Circulation 1984; 70 (suppl 1): 169–77.

Lutz DJ Noller KL Spittell JA Danielson GK Fish CR . Pregnancy and its complications following cardiac valve prostheses. Am J Obstet Gynecol 1978; 131: 460–68.

Kakkar W Cohen AT Emondson RA Phillips MJ Cooper DJ Das SK . Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal. Lancet 1993; 341: 259–65.

Leizorovicz A Haugh MC Chapuis FR Samama MM Boissel JP . Low-molecular weight heparin in prevention of peri-operative thrombosis. BMJ 1992; 305: 913–20.

Priollet P Roncato M Aiach M Housset E Poissonnier MH Chavinie J. Low molecular weight heparin in venous thrombosis during pregnancy. Br J Haematol 1986; 63: 605–606.

Many A Pauzner R Carp H Langeritz P Martinowitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol 1992; 28: 216–18.

Sturridge F Letsky EA de Swiet M. The use of low molecular weight heparin for thromboprophylaxis. Br J Obstet Gynaecol 1994; 101: 69–71.

Bergqvist D. Post-operative thromboembolism. New York: Springer-Verlag, 1983: 106–107.

Turpie AGG Forbes CD . Principles of prophylaxis in pregnancy and after gynaecological surgery. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 305–17.

Lowe GDO Greer IA Cooke TG Risk and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567–74.

Hathaway WE Bonnar J. Haemostatic disorders of the pregnant woman and newborn infant. New York: Elsevier, 1987.

Rutherford SE Phelen JP . Thromboembolic disease in pregnancy. Clin Perinatol 1986; 13: 719–39.

Wildsmith JAW McClure JM . Anticoagulant drugs and central nervous system blockade. Anaesthesia 1991; 46: 613–14.

Thorburn J Louden J Vallance R. Spinal and general anaesthesia in total hip replacement: Frequency of deep venous thrombosis. Br J Anaesth 1980; 52: 1117–21.

Chesebro JH Adams PC Fuster V. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. J Am Coll Cardiol 1986; 8: 41–56.

Mok CK Boey J Wang R Warfarin versus dipyridamole–aspirin + pentoxifylline–aspirin for the prevention of prosthetic heart valve thromboembolism – a prospective randomized clinical trial. Circulation 1985; 72: 1059–63.

Wang RYC Lee PK Chow JSF Chen WWC . Efficacy of low dose, subcutaneously administered heparin in treatment of pregnant women with artificial heart valves. Med J Aust 1983; 2: 126–28.

Lee PR Wang RYC Chow JSF Cheung KL Wong YCW Chan TR . Combined use of warfarin and adjusted sodium heparin during pregnancy in patients with an artificial heart valve. J Am Coll Cardiol 1986; 8: 221–24.

de Swiet M. Thomboembolism. Clin Haematol 1985; 14; 643–61.

Turpie AGG Gent M Laupacis A. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993; 329: 524–29.

Ginsberg JS Barron WM . Pregnancy and prosthetic heart valves. Lancet 1994; 344: 1170–72.

Winter JH Douglas AS . Congenital thrombotic problems in obstetrics and gynaecology. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1991: 431–58.

Rosendaal FR Bertina RM Reitsma PH . Evaluation of activated protein C resistance in stored plasma. Lancet 1994; 343: 1289–90.

Svensson PJ Dahlback B. Resistance to activated protein C as a basis of venous thrombosis. N Engl J Med 1994; 330: 517–22.

Cook G Walker ID McCall F Conkie JA Greer IA . Familial thrombophilia and activated protein C resistance: Thrombotic risk in pregnancy? Br J Haematol 1994; 87: 873–75.

Douglas AS Walker ID Bennett NB . A Scottish Hebridean antithrombin III deficient family – twelve years on. Scott Med J 1990; 35: 108–13.

Manson LM Bisland MP Greer IA Ludlam CA . Unfractionated and low molecular weight heparin prophylaxis in congenital antithrombin III deficiency. Br J Haematol 1991; 77 (suppl 1): 65.

Vandenbrouke JP Koster T Briet E Reitsma PH Bertina RM Rosendaal FR . Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–57.

Conard J Horellou MH van Dreden P Lecompte T Samama M. Thrombosis and pregnancy in congenital deficiencies in ATIII, protein C or protein S: Study of 78 women. Thromb Haemost 1990; 63: 319–20.

Lubbe WF Butler WS . Acquired defects of coagulation – the lupus anticoagulant. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 389–405.

Nilsson IM Felding P Lecander I Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women. Br J Haematol 1986; 62: 215–20.

Branch DW Scott JR Kochenour NK Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322–26.

Lubbe WF Butler WS Palmer SJ Liggins GC . Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol 1984; 91: 357–63.

Lubbe WF Walker EB . Chorea gravidarum associated with circulating lupus anticoagulant: Successful treatment of pregnancy with prednisone and aspirin therapy. Br Obstet Gynaecol 1983; 90: 487–90.

Cowchuk FS Reece A Balaban D Branch DW Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomised trial comparing prednisone with low dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318–23.

Buckley LM . The management of antiphospholipid antibody syndrome during pregnancy: A review of clinical studies. Rheumatol Rev 1994; 3: 181–86.

Walsh JJ Bonnar J Wright FM . A study of pulmonary embolism after deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen, phlebography and lung scanning. J Obstet Gynaecol Br Commonw 1974; 81: 311–15.

Vessey MP Mant D Smith A Yeates D. Oral contraceptives and venous thromboembolism: Findings in a large prospective study. BMJ 1986; 292: 526.

Carter CJ . Thrombosis in relation to oral contraceptives and hormone replacement therapy. In: Greer IA Turpie AGG Forbes CD eds. Haemostasis and thrombosis in obstetrics and gynaecology. London: Chapman & Hall, 1992: 371–88.